![[Updated] U.S. Air Force Mobilizes F-22s and F-35s as Situation in Middle East Escalates](https://theaviationist.com/wp-content/uploads/2025/06/F-22_F-35_CENTCOM-top.jpg)
![Israel drama and good news for the F-35: Paris Air Show Day 1 [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/06/IMG_1805-scaled-e1750092662883.jpg?#)
![[Updated] Sudden Deployment of Dozens of U.S. Air Force Tankers Raises Questions](https://theaviationist.com/wp-content/uploads/2025/03/Stratotanker100Years_2-e1750080240327.jpg)
Eli Lilly in talks over $1.3B deal for gene editing partner Verve Therapeutics: FT
Eli Lilly is in talks to buy gene editing partner Verve Therapeutics for up to $1.3 billion, according to a report in the Financial Times.
Eli Lilly is in talks to buy gene editing partner Verve Therapeutics for up to $1.3 billion, according to a report in the Financial Times.
